Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese people without diabetes and another one for people with diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback